Institute of Bioorganic Chemistry of the Russian Academy of Sciences

hemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences is the main center of physical-chemical biology and biotechnology in Russian Federation. It's included in the Department of biological sciences of Russian academy of sciences and performs activities connected with biochemical research of living matter. It researches molecular mechanisms of vital processes and their practical use in medicine and agriculture. Moreover the Institute develops fundamental and applied aspects of biotechnologies.

Address
117997, Russian Federation, Moscow, GSP-7, Ulitsa Miklukho-Maklaya, 16/10
Website
http://www.ibch.ru/

Subscribe to rss feed

Immunology

CMV infection 'disarms' the cell, inhibiting microRNA synthesis

An international research collaborative has discovered that in its early stages, CMV infection "disarms" cells, blocking their protective mechanisms by inhibiting the synthesis of miRNAs. The results of this study were published ...

Oncology & Cancer

Scientists discover how to stop the spread of metastasis

A group of researchers from the Institute of Bioorganic Chemistry of the Russian Academy of Sciences and Queen's University (Canada), in conjunction with the Institute of Macromolecular Compounds of the Russian Academy of ...

Medical research

Researchers develop computer simulation of body's heat response

For the first time, scientists at the M.M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences have successfully used computer-generated simulations to study the TRPV1-receptor ...

Alzheimer's disease & dementia

Scientists find a method of protection against Alzheimer's disease

A joint study on the Lynx1 protein has revealed that the protein competes with human nicotinic acetylcholine receptors for binding to amyloids, which are the main cause of Alzheimer's development. In the future, the protein ...

Neuroscience

Scientists develop a drug for the treatment of multiple sclerosis

A team of scientists has created a new form of a vaccine used for the treatment of multiple sclerosis, one of the most severe neurodegenerative autoimmune diseases. The drug has successfully passed pre-clinical trials and ...